Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lymphocytes from peripheral blood of rainbow trout are put in the presence of increasing concentrations of
substance P
(SP) and somatostatin (SOM). We have shown that SP stimulates and SOM inhibits lymphoproliferation and that the effects are dose dependent. These results suggest that SP and SOM receptors may exist on fish peripheral blood lymphocytes. When cells are stimulated by PHA or
LPS
, the presence of SP enhances the response to PHA whereas it only modifies the response to
LPS
to a slight extent. The presence of SOM inhibits PHA- or
LPS
-induced stimulation. The inhibition of the proliferation is higher in the case of
LPS
-stimulated cells. These results suggest that there is an unequal distribution of neuropeptide receptors among the various lymphocyte subpopulations.
...
PMID:In vitro effects of substance P and somatostatin on lymphoproliferation in rainbow trout (Salmo gairdneri). 137 68
Numerous soluble factors and their receptors contribute to the regulation of immune responses. An important area of investigation concerns defining the regulation of expression of such receptor/ligand pairs, since understanding such events are central in the quest to manipulate immune responses. Receptors for the neuropeptide,
substance P
, are present on a variety of leukocytes, and these receptor positive cells respond to in vitro stimulation with
substance P
in a variety of ways. Unfortunately, little is known about the regulation of expression of
substance P
or its receptor in leukocytes. Here we begin to address this question by examining the ability of macrophages to express mRNAs which encode
substance P
and its receptor. A radiolabeled oligonucleotide probe complementary to the mRNA which encodes
substance P
(i.e.,
preprotachykinin
mRNA) hybridized to a 1.3 kb RNA species present in rat macrophages. In addition, the expression of this RNA could be upregulated 6 to 8 fold when macrophages were stimulated with
LPS
. The ability of macrophages to synthesize and secrete immunoreactive-
substance P
was demonstrated by incorporation of L-[35S]methionine into material from macrophage cultures which could be recognized by a monoclonal antisubstance antibody. Macrophage RNA of approximately 3.1 kb in size was capable of hybridizing with an oligonucleotide probe complementary to rat brain
substance P
receptors. In addition, this RNA could be upregulated when cells were exposed to
LPS
. Taken together, these studies suggest that the genes used by neuronal cells and macrophages to encode
substance P
and its receptor are similar if not identical.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. 138 Feb 79
The IgA producing murine B lymphoma, CH12.LX.C4.4F10 (4F10) and the IgM producing murine lymphoma, CH12.LX.C4.5F5 (5F5) were found to express substantial numbers of
substance P
(SP) receptors having dissociation constants equal to 0.69 nM. Binding of SP by these B lymphoma cells was via the
tachykinin
-specific C-terminus sequence, Phe-X-Gly-Leu-Met-NH2, because SP, SP antagonist (D-Pro2-D-Phe7-D-Trp9-SP), eledoisin, and
substance K
could effectively inhibit radiolabeled SP binding, whereas the SP N-terminus fragment, SP (1-4), could not. The functionality of these receptors could be demonstrated by the ability of subnanomolar concentrations of SP to induce Ig secretion in a dose-dependent fashion. However, the presence of a second stimulus in these cultures was required to obtain maximal increases. IgA secretion by 4F10 cells was elevated only 25 to 37%, and IgM secretion by 5F5 cells was not significantly increased in cultures in which nanomolar concentrations of SP were present. Conversely, coculturing 5F5 cells with a suboptimal concentration of
LPS
(50 ng/ml) and 10(-10)M SP resulted in an approximate threefold increase in supernatant IgM when compared to control cultures stimulated with
LPS
alone. While not as dramatic, 10(-10) M SP also enhanced IgA secretion of
LPS
-stimulated 4F10 cells by approximately 45%. This enhancement of Ig secretion was SP-specific, as evidenced by the ability of 1000-fold excess of SP antagonist to block SP-induced, but not
LPS
-induced, Ig production. Clearly, SP could act synergistically with
LPS
to enhance Ig secretion; therefore, we questioned whether this augmentation was also reflected at the level of H chain mRNA expression. 10(-9)M SP induced modest increases (50 to 60%) in mu-chain mRNA expression by
LPS
-stimulated 5F5 cells when compared with cells stimulated with
LPS
alone. The 4F10 cells did not display this magnitude of difference for alpha-chain mRNA expression. Thus, although SP-induced increases of mu-chain mRNA by 5F5 cells may contribute to the increased Ig secretion observed by these
LPS
-activated lymphocytes, it is unlikely that increased mRNA expression can totally account for the threefold increases in secretion that were observed.
...
PMID:Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. 170 87
Production of O2- in response to FMLP, TNF, IFN-gamma, platelet activating factor,
LPS
,
substance P
, and PMA by human eosinophils in suspension and in contact with polystyrene ELISA plastic (PL) or biologic surfaces was studied. Monolayers of human endothelial cells (HEC) or PL coated with FCS, fibronectin, laminin, collagen types I and IV, fibrinogen, or fibrin were used as biologic surfaces. Only PMA and FMLP stimulated O2- generation by eosinophils in suspension. Eosinophils residing on HEC monolayers, either untreated or treated with
LPS
, were unresponsive to all stimuli except PMA. PMA induced O2- generation by eosinophils on all surfaces; FMLP on all surfaces but HEC monolayers; TNF and platelet-activating factor only on PL, fibrinogen, and fibrin;
LPS
and
substance P
only on PL. PMA was equally effective on eosinophils on surfaces and in suspension, whereas the effect of FMLP was greater on eosinophils on surfaces than on eosinophils in suspension. IFN-gamma was ineffective on any of the surfaces tested. These results indicate that biologic surfaces may profoundly affect the ability of eosinophils to respond with a respiratory burst to physiologically relevant soluble stimuli, the effect varying according to the nature of both the stimulus and the surface. Since the respiratory burst generates products of oxygen reduction that are toxic to several tissue components, it follows that biologic surfaces may modulate eosinophil-induced tissue injury.
...
PMID:Eosinophil activation on biologic surfaces. Production of O2- in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. 171 13
The effects of trichloroethylene (TRI), a widely used industrial solvent, on various immunological and toxicological parameters have been examined in Sprague-Dawley rats and B6C3F1 mice. Rats were administered TRI in vivo at 0.05, 0.5 and 5.0 mmol/kg per day intraperitoneally (i.p.) for 3 days. Mice were similarly treated with TRI at 10.0 mmol/kg. The highest TRI dose resulted in decreased splenocyte count and relative spleen weights, in rats and mice respectively and inhibition of hepatic natural killer cell (NK), natural cytotoxic cell (NC) and
NPK
cell (a newly described immune cell killing) activities in both rats and mice. High dose TRI in vitro resulted in minor decreases (less than 10%) in splenocyte viability, inhibition of
LPS
-stimulated mitogenesis in rat cells and marked inhibitions of NK and NC activities in all groups of effector cells. At the lowest in vitro dose mouse hepatic NK activity was still inhibited. Overall the data show that TRI is able to inhibit the activity of lymphocytotoxic cells which are involved in the immune surveillance of cancerous cells. This inhibition is particularly evident in the liver after in vivo administration and both liver and spleen cells after in vitro exposure. This suggests the possibility that compromised immune function may play a role in the carcinogenic responses in experimental animals on exposure to TRI.
...
PMID:Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. 176 17
Conditions are described for performing mitogen (Concanavalin A, Con A; lipopolysaccharide,
LPS
) and mixed lymphocyte reaction (MLR) cultures using serum-free medium. The effects of exogenously adding several gastrointestinal regulatory peptides (beta-endorphin,
substance P
, met-enkephalin, vasoactive intestinal peptide, bombesin and somatostatin) on the incorporation of 3H-methyl-thymidine was determined. It was observed that mitogen stimulation of lymph node cells with Con A was inhibited (70% of control) by vasoactive intestinal peptide (VIP) but spleen cells stimulated by
LPS
were insensitive to immunomodulation (98% of control). The ability of VIP to inhibit Con A induced thymidine incorporation was concentration dependent (10(-6) to 10(-18) M) and was not attributable to kinetic shifts or cell toxicity. None of the other tested neuropeptides affected Con A or
LPS
induced blastogenesis. MLR cultures were inhibited by VIP, beta-endorphin and somatostatin in a biphasic manner with maximal inhibition observed at 10(-8) to 10(-12) M. Both
substance P
and bombesin exhibited slight immunoenhancing properties at 10(-14) to 10(-18) M. Met-enkephalin was ineffective as an immunomodulator of MLR cultures. The utility of using serum-free medium in identifying neuropeptides with immunomodulatory properties are discussed.
...
PMID:Gastrointestinal regulatory peptides modulate mouse lymphocyte functions under serum-free conditions in vitro. 242 44
The inflammatory neuropeptide
substance P
acted as a costimulant for macrophage CSF-1-induced clonal proliferation of murine marrow-derived two signal-dependent mononuclear phagocyte progenitors.
Substance P
had no effect on clonal proliferation by progenitors responding solely to CSF-1.
Substance P
fragment 2-11 had no costimulatory activity; however, SP fragment 1-4 retained the full activity of the parent undecapeptide. Fragment 1-4 (ARG-PRO-LYS-PRO), a peptide containing a PRO residue between two positive charges, is a tuftsin-like (THR-LYS-PRO-ARG) tetrapeptide, and tuftsin exerted an identical costimulatory effect.
Substance P
, SP:1-4, and tuftsin were optimally effective as costimulants at 10(-7) to 10(-6) M. (ALA1)-tuftsin, an inhibitory analog of tuftsin, was a potent negative regulator of two signal-dependent colony formation. (ALA1)-tuftsin at concentrations less than or equal to 10(-9) M exerted dose-dependent inhibition of the positive effects of optimal concentrations of all of the co-stimulants tested, including bacterial
LPS
. The inhibitory tetrapeptide was equivalent in activity to ferritin, an established inhibitor of two signal-dependent colony formation. The results indicated that SP may influence myelopoiesis in addition to its other inflammatory and immunopotentiating properties. In addition, a potentially valuable modulator of SP and
LPS
responses in this system, (ALA1)-tuftsin, was identified.
...
PMID:Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect. 245 23
The intravenous injection of 10 microgram of a lipopolysaccharide extracted from E. Coli to rabbits leads to the appearance of a hypotensive effect for des-Arg9-BK and increases significantly the vasodilator effect of this peptide in isolated hearts and its contractile effects in strips of large arteries and veins.
LPS
elicits these responses when administered 5 or 20 h before anesthesia; the hypotensive response of animals receiving
LPS
just before anaesthesia is similar to that of untreated rabbits. All actions of des-Arg9-BK in vivo, in isolated hearts and in isolated tissues are blocked by des-Arg10,[Leu9]-kallidin (KD), a specific inhibitor of kinins B1-receptor. These data are taken as evidence of the appearance of B1-response to kinins in the few hours following
LPS
injection. The response of the animals, perfused organs and isolated tissues to other agonists, such as
substance P
or [Tyr(Me)8]-BK (an activator of B2-receptors for kinins) are not affected by the treatment with
LPS
nor are they modified by the antagonist des-Arg10,[Leu9]-KD. The present data, together with previous studies on the sensitization mechanism of B1-receptor containing preparations, suggest that
LPS
induces the formation of B1-receptors in the rabbit, within a few hours. The activation of B1-receptors by des-Arg9-BK produces hypotension, coronary vasodilation and stimulation of large arteries and veins isolated and suspended in vitro. Some large arteries and veins (e.g. the aorta and the anterior mesenteric vein) as well as some peripheral vascular beds (e.g. the coronary vessels) have the ability of generating B1-receptors, while other organs (e.g. the external jugular vein) have not or very little. The reason for this phenomenon as well as the intimate mechanism by which
LPS
induces the formation of B1-receptors remain to be elucidated.
...
PMID:Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. 611 53
The neuropeptide,
substance P
(SP), can stimulate secretion of TNF-alpha from macrophages. Neuroglia have SP receptors and subserve various macrophage-like functions in the central nervous system. We investigated whether SP stimulates secretion of TNF-alpha from primary cultures of neuroglial cells containing both astrocytes (approximately 90%) and microglia (approximately 10%). SP alone had no effect; however in the presence of
LPS
(10 ng/ml), SP (1 to 10 nM) caused a dose-dependent increase in TNF-alpha secretion above the level measured in response to
LPS
alone. The effective doses of SP correlated with 125I-labeled Bolton Hunter-conjugated SP binding (Kd 0.2 nM) to these cultures. Incubation with
LPS
did not change the number or affinity of SP-binding sites. In cultures enriched for microglia (> 99% pure),
LPS
stimulated the secretion of TNF-alpha but SP caused no enhancement. Microglia have no detectable 125I-labeled Bolton-Hunter-conjugated SP binding sites in the presence or absence of
LPS
. These results indicate that the action of SP is mediated through astrocytes. We investigated whether IL-1 mediates the SP enhancement of TNF-alpha secretion. Addition of IL-1-neutralizing antisera to mixed cultures stimulated with both
LPS
and 10 nM SP decreased TNF-alpha secretion to the level observed with
LPS
alone.
LPS
alone stimulated the secretion of IL-1 in a dose-dependent manner in the primary cultures, and this
LPS
-mediated IL-1 secretion was enhanced by SP. This enhancement was not observed in microglial cultures. SP may therefore play a role in neuropathologies in which these cytokines have been implicated.
...
PMID:Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide. 750 35
We have isolated and characterized the human cardiac mast cell (CMC) and compared this novel mast cell (MC type with MC obtained from uterus, skin, and lung. Heart tissue was obtained from 14 patients with cardiomyopathy (CMP, heart transplantation). CMC were isolated by enzymatic digestion using collagenase, pronase-E, hyaluronidase, and DNAse. Substantial amounts of CMC (0.5% to 1.5% of isolated cells) were found in the atrial appendages but not in ventricular digests or other sites of the heart (< 0.1%). In situ staining of atrial tissue revealed the presence of CMC in the myocardium (2.16 +/- 0.7 MC/mm2), endocardium (2.24 +/- 0.9 MC/mm2), and epicardium. As assessed by combined toluidine blue/immunofluorescence staining with monoclonal antibodies (MoAbs), isolated CMC expressed surface IgE, the receptor for stem cell factor (c-kit receptor/CD117), the p24 antigen (CD9), the Pgp-1 homing receptor (CD44), the pan leukocyte antigen (CD45), and the ICAM-1 antigen (CD54). CMC were not recognized by MoAbs to lymphocyte function associated antigen 2 (LFA-2; CD2), T-cell receptor (TcR; CD3), T4 antigen (CD4), LFA-1 alpha-chain (CD11a), C3biR alpha-chain (CD11b), CR4 alpha-chain (CD11c),
LPS
-R related Ag (CD14), 3-FAL/x-hapten (CD15), Fc gamma RIII (CD16), lactosylceramid (CDw17), the B-cell antigen CD19, or CR1 (CD35). In situ expression of leukocyte antigens on CMC was demonstrable by indirect immunoperoxidase staining technique and double-labeling immunohistochemistry. Almost all CMC (90%) reacted with MoAbs against tryptase and chymase and thus were MCTC. Cardiac mast cells were also stained by the heparin-binding dye Berberine sulfate and expressed measurable amounts of histamine (4.6 +/- 1.4 pg per cell). Cross linking of either IgE receptor or SCF receptor (c-kit) on CMC resulted in histamine secretion (non-specific release: < 6% of total histamine, alpha IgE induced: 12% to 52%; SCF-induced release: 9% to 18%), whereas neither
substance P
(a skin MC agonist) nor the basophil agonist FMLP showed an effect on CMC. Together, the CMC is an MCTC primarily located in the appendage of the atrium. This novel type of MC exhibits surface membrane antigen and functional properties similar to those of lung and uterus MC.
...
PMID:The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. 752 50
1
2
3
4
5
Next >>